# Biosurf Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/biosurf-biotech

- Industry: Medical Devices & Equipment
- Headquarters: Suzhou, China
- Website: www.biosurf.cn
- Total disclosed funding: $16M
- Latest round: Series B (Aug 16, 2022)
- Investors on record: 8

## About

Based in Suzhou, China, and established in 2017, Biosurf Biotech operates as a medical device coating material provider that provides a medical coating whole industry chain technology platform. The company has multiple certifications, including National High-tech Enterprise, Postgraduate Workstation in Jiangsu Province, Foreign Academician Workstation in Suzhou. The company cooperated with Suzhou University to establish the Baisifu Collaborative Innovation Center. The company also established a branch office in Shenzhen. The company's main products can be categorized into three categories which are functional medical coating, medical coating curing equipment and coating performance testing equipment. Products within include SurfLubri hydrophilic lubricant coating series, antibacterial coating series and anticoagulation coating series. The equipment includes medical coating coating curing machine MUA-M-1150 series, friction tester FW-01 type. The company also provides coating technology services, coating outsourcing services and inspection and testing services for coating products. In July 2025, Biosurf Biotech closed a venture funding, which was led by new investor Jolmo Capital, followed by returning investors Leader Venture Capital, and LH Ventures. The company will use the funding in July 2025 to accelerate its process of technological innovation and market globalization.

## Funding rounds

- Series B, Aug 16, 2022 — YuanBio Venture, LH Ventures
- Series B, Apr 13, 2022, $16M — Huatai Zijin Investment, HYVIEW Group, Guoqian Venture Capital, Essence Capital, Leader Venture Capital
- Angel, May 31, 2018 — Bohe Angel Fund

## Investors

- Bohe Angel Fund — Angel
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series B
- HYVIEW Group — Series B
- Guoqian Venture Capital (https://capitalatlas.ai/funds/guoqian-venture-capital) — Series B
- Essence Capital — Series B
- Leader Venture Capital (https://capitalatlas.ai/funds/leader-venture-capital) — Series B
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B
- LH Ventures (https://capitalatlas.ai/funds/lh-ventures) — Series B
